Smarca2 in Cancer

Smarca2 in Cancer

by | May 1, 2021

Therapeutic area: Oncology Disease: Non Small Cell Lung Cancers (NSCLC) / other cancers Monogenic inroad: Smarca 2 Cellular Model: Patient-derived cell line Project Origin: DKFZ, Prof. Nicolas Gunkel Medical need: SMARCA4 mutations have been identified in a high...

We are currently working on a new website to reflect our technological capacities for AI powered cellular profiling and prioritized pipeline open for private investments.

--------------------
In the meantime, please follow us on LinkedIn or contact us per e-mail.